Corresponding to therapeutic efficacy, administration of IL-21R-Fc fusion protein to BXSB.B6-Yaa+/J mice, another model of lupus, decreased lymphocyte activation and circulating IgG1 levels [47]. Here, IL21R is linked to systemic lupus erythematosus.